Braincure Biotech / Braincreuzen Taipei 106 Taiwan

by HannahsDad Fri Dec 23, 2016 12:24 pm

Braincure Biotech at http://braincure-biotech.com

Braincure Biotech is dedicated to pursuing the development and commercialization of novel treatment approaches in the fight against dementias, with a particular focus on Alzheimer’s Disease.

We design, discover and develop therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins. Braincure Biotech’s two proprietary technology platforms create antibodies, small molecules and vaccines to address large markets across a broad spectrum neurodegenerative disorders.

Alzheimer’s disease (AD) is the largest indication addressed by our products but Braincure Biotech’s innovative, highly differentiated and disease-modifying therapies are capable of shifting the paradigm in the treatment of other neurodegenerative diseases such as Down syndrome, Parkinson’s disease, Tauopathies, Glaucoma and Huntington’s.

The most advanced of these is Braincreuzen, an anti-Abeta antibody that is licensed to Genentech entering phase III development.

Alzheimer’s disease affects 44 million people worldwide and by 2030 this number will rise to 76 million at a cost of care of $408 billion. Current therapies have proven to be effective only for a limited period of time and do not significantly delay disease progression. In contrast, Braincure Biotech’s therapies are designed to prevent, modify, delay or stop disease progression.

Undoubtably worthy. Now see https://covalentdata.com/company/ac-immune